Pfizer Corporation has agreed to pay $491 million to resolve allegations stemming from a whistleblower suit which alleged that its subsidiary Wyeth illegally marketed the transplant drug Rapamune for uses not approved by the FDA including for patients getting liver, lung heart and other transplants--dangerous uses. Rapamune was approved in 1999 only for ise...

The Department of Justice, on behalf of the Food and Drug Administration has filed a case against Sage Pharmaceuticals Inc, it's President and Director of Corporate Quality for manufacturing and distributing unapproved drugs. The required FDA approval process is to make sure that drugs manufactured and distributed to consumers are safe and effective for...

The Swiss drug manufacturer Novartis has dismissed 18 sales executives for fabricating and inflating sales numbers of its diabetes drug Galvus. The Πsales executives reportedly used sales incentives provided by the company to buy stocks from wholesalers and show an increase in sales of the drug in order to meet their target quota....

The head of GlaxoSmithKline's (GSK) Research & Development operations in China has been fired and another researcher has resigned following a GSK probe into data fabrication on interleukin-7 research published in Nature Magazine. Nature reported that Jingwu Zhang of GSK had found data suggesting that the signaling molecule interleukin-7 caused a subset of T...

Following the revelations concerning the massive fraudulent data submissions by India's generic drug manufacturer Ranbaxy which agreed to pay $500 million to settle a False Claims Act case, the Department of Justice has publicly said that it will be taking an especially hard look at drug manufacturers abroad. The DOJ wants to make sure...

Despite the fact that India's largest drug maker, Ranbaxy, which manufactures generic drugs was caught lying to the FDA about test results and about quality control, the company's sales appear strong here. According to analysts Ranbaxy has a solid plan to cut costs by 15 percent once it starts selling the products made in...

Last week, the Indian generic drug manufacturer Ranbaxy pleaded guilty to seven felony counts involving manufacturing and selling its pharmaceuticals and agreed to pay $500 million, the largest fine of its kind against a generic drug maker. The evidence mounted by the government included forging and falsifying data submitted to the Food and Drug...

The Department of Justice has filed a case against Pharmaceutical manufacturer Novartis, asserting that it provided illegal kickbacks to pharmacies in the form of discounts and rebates to promote its drug Myfortic. This, says the feds, lures the pharmacists to become salespeople for its drugs and that is illegal. The numbers are not minor....